Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
By V. Moreno, F. Bosch, N. Muñoz, C. Meijer, Keerti V. Shah, J. Walboomers, R. Herrero, Silvia Franceschi. The Lancet, 2002
672 citations recorded by the source corpus.
Subfields: Epidemiology, Obstetrics and Gynecology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/b33b6550523b519083ba9b7d776ba32bed1be411
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. (2003, neutral): “[6–8] 2.2 (1.0 to 5.0) §[ 7] 3.9 (1.9 to 7.9) [ 9 ] 1.4 (0.6 to 3.4)§”
- The epidemiology of human papillomavirus infections. (2005, background): “Still, in the United States, ulti-parity or integration of HPV into the host chromoso ight play a role in risk of invasion (Deacon et al., 2000 instein and Goldberg, 2002; Hildesheim et al., 2001; nd Lambert, 1995; Moreno et al., 2002; Munoz et al., 2 mith et al., 2002).”